№ files_lp_3_process_9_33727
File format: docx
Character count: 3230
File size: 35 KB
The document outlines the ERAS protocol for colorectal surgery, detailing pre-operative, intra-operative, and post-operative procedures, along with patient instructions and medication management.
Year:
2017
Region / City:
Not specified
Topic:
Colorectal Surgery, ERAS Protocol
Document Type:
Medical Protocol
Organization / Institution:
STTAR Clinic
Author:
Troy Beaumont
Target Audience:
Healthcare professionals involved in colorectal surgery
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
10/18/17
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Document Type:
Procedural Instruction
Subject:
Data Import and Personnel Management
Related Systems:
ERAS; New Innovations
Process Steps:
Marking Trainee Status; API Data Import; Medical School Matching
Responsible Role:
Designated Institutional Official (DIO)
Associated Office:
MMCGME Services
Target Audience:
Program Administrators
Required Access:
ERAS Account; New Innovations Personnel Module
Technical Method:
API Connection
Status Mapping:
Program Status Mapping and Advancement Section
User Account Provision:
Automatic Username and Password Creation on Import
Year:
2026
Region / City:
Not specified
Topic:
Lung cancer morphology and survival analysis
Document Type:
Research Supplement
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, oncologists
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United Kingdom
Theme:
Colorectal Cancer Referral Guidelines
Document Type:
Medical Guidelines
Organization:
National Health Service (NHS)
Author:
National Institute for Health and Care Excellence (NICE), British Society of Gastroenterology (BSG), Association of Coloproctology of Great Britain and Ireland (ACPGBI)
Target Audience:
Healthcare professionals in primary and secondary care
Effective Period:
From August 2023
Date of Approval:
August 2023
Date of Amendments:
None mentioned
Year:
2017
Note:
Region / City
Topic:
Colorectal cancer screening, medical diagnostics
Document Type:
Clinical guideline
Organization / Institution:
HERC
Target Audience:
Healthcare professionals, medical reviewers
Approval Date:
November 2017
Year:
2023
Note:
Region / City
Topic:
Colorectal Cancer Screening
Document Type:
Policy
Organization:
Example Clinic
Target Audience:
Healthcare providers
References:
National Association of Community Health Centers, Colorectal Cancer Society
Year:
2021
Region / City:
New York State
Subject:
Colorectal cancer screening improvement
Document Type:
Request for Proposals
Agency / Institution:
Health Research, Inc. (HRI) and New York State Department of Health (NYSDOH)
Author:
Health Research, Inc. (HRI) and NYSDOH
Target Audience:
Federally Qualified Health Centers (FQHCs)
Period of Validity:
October 1, 2021 – December 31, 2024
Approval Date:
August 11, 2021
Amendment Date:
N/A
Year:
2019
Region / City:
Vienna, Europe
Theme:
Colorectal surgery, patient safety, surgical quality improvement
Document type:
Study protocol
Organization / Institution:
European Society of Coloproctology (ESCP)
Authors:
Mary L Venn, James Glasbey, Dmitri Nepogodiev, Elizabeth Li, Ana Minaya-Bravo, Ionut Negoi, Matteo Frasson, Richard Hooper, Charles Knowles, Dion Morton
Target audience:
Surgeons, anaesthetists, operating room staff
Study period:
Multi-phase, ongoing
Ethics approval:
Health Research Authority (HRA), REC reference 19/HRA/5656
Clinical trial registration:
NIHR CRN IRAS ID 272250, ClinicalTrials.gov NCT04270721
Funding:
ESCP and Ethicon (educational grant)
Conflict of interest:
MF consults for Johnson & Johnson Medical N.V.; other authors declare no conflicts
Type of intervention:
Hospital-level education-based quality improvement programme
Primary outcome:
30-day anastomotic leak rate
Year:
2019
Region / City:
Wellington, New Zealand
Topic:
Colorectal cancer, chemotherapy regimens
Document type:
Draft definitions
Organization / Institution:
Ministry of Health, New Zealand
Author:
Ministry of Health
Target audience:
Medical oncologists, pharmacists, nurse specialists, other DHB staff
Period of validity:
Not specified
Approval date:
Not specified
Date of last modification:
Not specified
Year:
2026
Region / City:
Not specified
Topic:
Colorectal cancer, miRNA, HOXB7, GALNT5, Cancer cell migration
Document type:
Research Supplementary Materials
Organization/Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, medical professionals
Effective period:
Not specified
Approval date:
Not specified
Date of modification:
Not specified
Contextual description:
Supplementary materials detailing experimental methods and procedures used to study the role of miR-196b-5p in cancer cell migration and its potential as a prognostic factor in colorectal cancer.
Year:
2023
Region / city:
Global
Subject:
Postoperative biomarkers, colorectal cancer
Document Type:
Research data
Institution:
Various research institutions
Author:
Multiple authors
Target Audience:
Researchers, medical professionals
Effective Period:
N/A
Approval Date:
24.02.2023
Revision Date:
N/A
Note:
Contextual description
Year:
2010-2017
Region / City:
Africa, Latin America
Topic:
Colorectal Cancer, Cancer Registries
Document Type:
Statistical Table
Institution:
Various Cancer Registries
Authors:
Not specified
Target Audience:
Researchers, Medical Professionals
Period of Validity:
2010-2017
Date of Approval:
Not provided
Date of Revisions:
Not provided
Year:
Not specified
Region / city:
Not specified
Topic:
Colorectal cancer, gene expression, proteomics
Document type:
Research data
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers in oncology and molecular biology
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Region / City:
Europe, United States, Australia, Canada
Subject:
Colorectal Cancer Research
Document Type:
Funding and Acknowledgements Summary
Institutions:
National Cancer Institute, National Institutes of Health, University Hospital Center of Nantes, German Research Council, Instituto de Salud Carlos III, Charles University, and multiple international cancer research consortia
Authors:
Various contributing researchers from multiple studies
Target Audience:
Scientific community and research collaborators
Funding Sources:
NIH, NCI, European Union, regional councils, cancer societies, foundations, public–private partnerships
Research Programs:
GECCO, ASTERISK, ATBC, BWHS, CLUE II, ColoCare, CCFR, COLON, Nqplus, COLO2&3, CORECT, CORSA, CPS-II, CRCGEN, Czech Republic CCS, DACHS, DALS, EDRN, EPIC
Acknowledged Services:
Genotyping/Sequencing by CIDR, Scientific Computing Infrastructure at Fred Hutch
Collaborating Registries:
Maryland Cancer Registry, state and international cancer registries
Description:
Compilation of funding acknowledgements, institutional collaborations, and registry contributions across multiple international colorectal cancer studies, providing transparency on grants, support, and research infrastructure involved in data collection and analysis.
Year:
2020
Region / city:
Worldwide
Topic:
Colorectal cancer, ctDNA
Document type:
Review article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, oncologists, medical professionals
Effective date:
Not specified
Date of changes:
Not specified
Year:
2021
Region / City:
Buenos Aires, Argentina
Document Type:
Scientific article
Journal:
World Journal of Gastroenterology
Authors:
María Belén Novoa Díaz, Pedro Matías Carriere, María Julia Martín, Natalia Calvo, Claudia Gentili
Affiliation:
Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur (UNS)-INBIOSUR (CONICET-UNS); Departamento de Química, Universidad Nacional del Sur (UNS)-INQUISUR (CONICET-UNS)
Funding:
Agencia Nacional de Promoción Científica y Tecnológica, Consejo Nacional de Investigaciones Científicas y Técnicas, Instituto Nacional del Cáncer, Universidad Nacional del Sur
Manuscript Number:
67536
Manuscript Type:
FRONTIER
Received Date:
April 27, 2021
Revised Date:
June 14, 2021
Accepted Date:
August 23, 2021
Published Online:
2021
Keywords:
Parathyroid hormone-related protein, Colorectal cancer, Tumor biomarkers, Neoplastic processes, Drug resistance, Tumor microenvironment
Corresponding Author:
Claudia Gentili, [email protected]
Target Audience:
Researchers and clinicians in oncology and molecular biology
Document Type:
Supplementary research materials
Scientific Field:
Genetic Epidemiology
Research Topic:
Gene–body mass index interactions in colorectal cancer risk
Genes / Locus Studied:
FMN1, GREM1, rs58349661
Methods:
Genome-wide interaction analysis, SNP association tests, EDGE two-step procedure
Statistical Elements:
1DF and 3DF tests, odds ratios, confidence intervals, principal components analysis
Figures:
Q-Q plots, Manhattan plots, SNP interaction plots, functional annotation plots
Tables:
Participant descriptions, sample sizes by subtype and center, SNP association results, BMI-stratified analyses, gene expression interaction results
Data Sources:
Multiple international colorectal cancer studies and cohorts
Study Designs Included:
Cohort, case-control, case-series
Countries Represented:
USA, Canada, Australia, Finland, Austria, Spain, Czech Republic, Germany, United Kingdom and other European cohorts
Genotyping Platforms:
Illumina Oncoarray, Illumina OmniExpress, Illumina OmniExpressExome, Illumina 300K, Illumina 1M, Affymetrix Axiom
Population:
Participants from international colorectal cancer genetic studies
Content Sections:
Figures S1–S5, Tables S1–S7, Supplementary Methods, Funding and Acknowledgements
Year:
2026
Region / City:
Aberdeen, UK
Subject:
Clinical trial coordination for colorectal liver metastasis
Document Type:
Agreement
Organization / Institution:
NHS Grampian / University of Aberdeen Medical School
Partner Institution:
[Redacted hospital department]
Authors / Signatories:
Coordinating Centre, Partner Institution representatives
Target Audience:
Clinical researchers and trial coordinators
Effective Date:
[Redacted]
Trial Name:
LORDS-M
Regulatory Compliance:
GDPR, GCP, PIPL, Data Security Law, Declaration of Helsinki 1996
Responsibilities:
Coordination of trial, data handling, adherence to protocol
Trial Phase:
Observational / Audit